Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.
Jones DA, Rathod KS, Williamson A, Harrington D, Andiapen M, van Eijl S, Westwood M, Antoniou S, Schilling RJ, Ahluwalia A, Mathur A. Jones DA, et al. Among authors: antoniou s. Int J Cardiol. 2018 Sep 1;266:1-6. doi: 10.1016/j.ijcard.2018.01.029. Int J Cardiol. 2018. PMID: 29887423 Clinical Trial.
Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction.
Jones DA, Rathod KS, Howard JP, Gallagher S, Antoniou S, De Palma R, Guttmann O, Cliffe S, Colley J, Butler J, Ferguson E, Mohiddin S, Kapur A, Knight CJ, Jain AK, Rothman MT, Mathur A, Timmis AD, Smith EJ, Wragg A. Jones DA, et al. Among authors: antoniou s. Heart. 2012 Dec;98(23):1722-7. doi: 10.1136/heartjnl-2012-302414. Epub 2012 Oct 10. Heart. 2012. PMID: 23053711
Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction.
Jones DA, Pellaton C, Velmurugan S, Rathod KS, Andiapen M, Antoniou S, van Eijl S, Webb AJ, Westwood MA, Parmar MK, Mathur A, Ahluwalia A. Jones DA, et al. Among authors: antoniou s. Circ Res. 2015 Jan 30;116(3):437-47. doi: 10.1161/CIRCRESAHA.116.305082. Epub 2014 Dec 15. Circ Res. 2015. PMID: 25512434 Free PMC article. Clinical Trial.
Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients.
Rathod KS, Antoniou S, Avari P, Ding N, Wright P, Knight C, Jain AK, Mathur A, Smith EJ, Weerackody R, Wragg A, Jones DA. Rathod KS, et al. Among authors: antoniou s. JRSM Cardiovasc Dis. 2017 Oct 5;6:2048004017734431. doi: 10.1177/2048004017734431. eCollection 2017 Jan-Dec. JRSM Cardiovasc Dis. 2017. PMID: 29051816 Free PMC article.
Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes.
Antoniou S, Colicchia M, Guttmann OP, Rathod KS, Wright P, Fhadil S, Knight CJ, Jain AK, Smith EJ, Mathur A, Weerackody R, Wragg A, Jones DA. Antoniou S, et al. Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):283-289. doi: 10.1093/ehjqcco/qcx041. Eur Heart J Qual Care Clin Outcomes. 2018. PMID: 29126112
368 results